185 related articles for article (PubMed ID: 29439954)
21. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
Ustaszewski A; Paczkowska J; Janiszewska J; Bernhart SH; Bein J; Russiñol N; Hansmann ML; Chapaprieta V; Martín-Subero JI; Siebert R; Hartmann S; Giefing M
PLoS One; 2023; 18(3):e0283186. PubMed ID: 36961799
[TBL] [Abstract][Full Text] [Related]
22. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
23. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
24. A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.
Feys T; Poppe B; De Preter K; Van Roy N; Verhasselt B; De Paepe P; De Paepe A; Speleman F
Haematologica; 2007 Jul; 92(7):913-20. PubMed ID: 17606441
[TBL] [Abstract][Full Text] [Related]
25. Expression of FoxO3a in clinical cases of malignant lymphoma.
Ikeda J; Tian T; Wang Y; Hori Y; Honma K; Wada N; Morii E
Pathol Res Pract; 2013 Nov; 209(11):716-20. PubMed ID: 24021689
[TBL] [Abstract][Full Text] [Related]
26. A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells.
Zahn M; Marienfeld R; Melzner I; Heinrich J; Renner B; Wegener S; Mießner A; Barth TF; Dorsch K; Brüderlein S; Möller P
Blood; 2017 Mar; 129(11):1480-1490. PubMed ID: 28082443
[TBL] [Abstract][Full Text] [Related]
27. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
28. Expression of ELF1, a lymphoid ETS domain-containing transcription factor, is recurrently lost in classical Hodgkin lymphoma.
Paczkowska J; Soloch N; Bodnar M; Kiwerska K; Janiszewska J; Vogt J; Domanowska E; Martin-Subero JI; Ammerpohl O; Klapper W; Marszalek A; Siebert R; Giefing M
Br J Haematol; 2019 Apr; 185(1):79-88. PubMed ID: 30681722
[TBL] [Abstract][Full Text] [Related]
29. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
[TBL] [Abstract][Full Text] [Related]
30. FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.
Imada K; Shiota M; Kuroiwa K; Sugimoto M; Abe T; Kohashi K; Yokomizo A; Eto M; Naito S; Oda Y
Prostate; 2017 Feb; 77(2):145-153. PubMed ID: 27699813
[TBL] [Abstract][Full Text] [Related]
31. MiR-96 expression in prostate cancer and its effect on the target gene regulation.
Bao YH; Wang Y; Liu Y; Wang S; Wu B
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4548-4556. PubMed ID: 29131261
[TBL] [Abstract][Full Text] [Related]
32. FoxO3a mediates glioma cell invasion by regulating MMP9 expression.
Xu K; Pei H; Zhang Z; Dong S; Fu RJ; Wang WM; Wang H
Oncol Rep; 2016 Nov; 36(5):3044-3050. PubMed ID: 27633065
[TBL] [Abstract][Full Text] [Related]
33. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
Baus D; Pfitzner E
Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
[TBL] [Abstract][Full Text] [Related]
34. Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.
Wein F; Otto T; Lambertz P; Fandrey J; Hansmann ML; Küppers R
Haematologica; 2015 Oct; 100(10):1320-6. PubMed ID: 26160878
[TBL] [Abstract][Full Text] [Related]
35. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
Yuan Y; Kluiver J; Koerts J; de Jong D; Rutgers B; Abdul Razak FR; Terpstra M; Plaat BE; Nolte IM; Diepstra A; Visser L; Kok K; van den Berg A
Am J Pathol; 2017 Jun; 187(6):1343-1355. PubMed ID: 28432871
[TBL] [Abstract][Full Text] [Related]
36. HLA-G expression and role in advanced-stage classical Hodgkin lymphoma.
Caocci G; Greco M; Fanni D; Senes G; Littera R; Lai S; Risso P; Carcassi C; Faa G; La Nasa G
Eur J Histochem; 2016 Apr; 60(2):2606. PubMed ID: 27349312
[TBL] [Abstract][Full Text] [Related]
37. miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene.
Ji WG; Zhang XD; Sun XD; Wang XQ; Chang BP; Zhang MZ
J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):882-888. PubMed ID: 25480585
[TBL] [Abstract][Full Text] [Related]
38. Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.
Ikeda J; Mamat S; Tian T; Wang Y; Rahadiani N; Aozasa K; Morii E
Am J Pathol; 2010 Dec; 177(6):3081-8. PubMed ID: 20952592
[TBL] [Abstract][Full Text] [Related]
39. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
[TBL] [Abstract][Full Text] [Related]
40. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]